Abstract
Functional sensitization and structural plasticity in the nociceptive pathways and modulatory networks in the peripheral and central nervous system develop following tissue and nerve injury and result in persistent or chronic pain, a major challenge to clinical management. Development of novel analgesic drugs requires a better understanding of the molecular and cellular mechanisms underlying persistent pain. Research during the last three decades has focused on the involvement of neuronal mechanisms in persistent pain. Recently accumulating evidence indicates that reactive glial cells play a critical role in peripheral and central sensitization during the development of persistent pain in variety of animal pain models. The purpose of this review is to highlight important recent advances in astrocytic mechanisms in experimentally persistent pain and the potential to use this information to develop new drugs targeting astrocytic signaling in the treatment of pathological pain.
Keywords: Astrocyte, signal transduction, proinflammatory cytokines, neronal plasticity, pain, analgesic drugs, tissue injury, astrocytic signaling, CNS, peripheral sensitization
Current Signal Transduction Therapy
Title: Astrocytic Signaling in Persistent Pain
Volume: 7 Issue: 1
Author(s): Yu-Xia Chu, Zhi-Qi Zhao and Feng Wei
Affiliation:
Keywords: Astrocyte, signal transduction, proinflammatory cytokines, neronal plasticity, pain, analgesic drugs, tissue injury, astrocytic signaling, CNS, peripheral sensitization
Abstract: Functional sensitization and structural plasticity in the nociceptive pathways and modulatory networks in the peripheral and central nervous system develop following tissue and nerve injury and result in persistent or chronic pain, a major challenge to clinical management. Development of novel analgesic drugs requires a better understanding of the molecular and cellular mechanisms underlying persistent pain. Research during the last three decades has focused on the involvement of neuronal mechanisms in persistent pain. Recently accumulating evidence indicates that reactive glial cells play a critical role in peripheral and central sensitization during the development of persistent pain in variety of animal pain models. The purpose of this review is to highlight important recent advances in astrocytic mechanisms in experimentally persistent pain and the potential to use this information to develop new drugs targeting astrocytic signaling in the treatment of pathological pain.
Export Options
About this article
Cite this article as:
Chu Yu-Xia, Zhao Zhi-Qi and Wei Feng, Astrocytic Signaling in Persistent Pain, Current Signal Transduction Therapy 2012; 7 (1) . https://dx.doi.org/10.2174/157436212799278052
DOI https://dx.doi.org/10.2174/157436212799278052 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Immunophilin Dysfunction and Neuropathology
Current Medicinal Chemistry Therapeutic Value of Adeno Associated Virus as a Gene Therapy Vector for Parkinson's Disease – A Focused Review
Current Gene Therapy Stem Cells in Pharmaceutical Biotechnology
Current Pharmaceutical Biotechnology Cognitive Impairment with Vascular Impairment and Degeneration
Current Neurovascular Research Dose-Response Effects of the CM11 as a Short Cationic Antimicrobial Peptide on Histopathological and Biochemical Changes in Mice
Current Chemical Biology Modern Approaches to Tissue Engineering of the Spinal Cord: Analytical Review
Current Regenerative Medicine (Discontinued) P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential
CNS & Neurological Disorders - Drug Targets Treating Cancer and No-Cancer Pain in Older and Oldest Old Patients
Current Pharmaceutical Design Cell Culture Models of Oxidative Stress and Injury in the Central Nervous System
Current Neurovascular Research Are Hsp90 Inhibitors Good Candidates Against Covid-19?
Current Protein & Peptide Science Relaxin Receptors - New Drug Targets for Multiple Disease States
Current Drug Targets NMDA Neurotransmission Dysfunction in Mild Cognitive Impairment and Alzheimers Disease
Current Pharmaceutical Design The Blood-Brain Barrier in NeuroAIDS
Current HIV Research NEP1-40-overexpressing Neural Stem Cells Enhance Axon Regeneration by Inhibiting Nogo-A/NgR1 Signaling Pathway
Current Neurovascular Research Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases
Current Molecular Medicine Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology Aquaporins and Glia
Current Neuropharmacology Engineered Magnetic Core-Shell Structures
Current Pharmaceutical Design Sphingolipids in Genetic and Acquired Forms of Chronic Kidney Diseases
Current Medicinal Chemistry Signaling Through Rho GTPase Pathway as Viable Drug Target
Current Medicinal Chemistry